Nuwellis to report Q3 2026 financial results on November 12 before US market open.

Nuwellis, Inc., a medical technology company focused on cardiorenal solutions, will announce its financial results for the third quarter and first nine months of 2026 on November 12, before the U.S. markets open. The company will hold a conference call at 9:00 a.m. Eastern time to discuss the results. This update is important for investors tracking Nuwellis' progress in developing technologies for acute and chronic cardiorenal care. The webcast and call details are publicly available for interested parties to join and learn about the company's financial performance and outlook.

Nuwellis Inc shares are currently priced at USD 5.25 on Pluang as of November 4, 2026, 20:41 WIB. The stock has experienced a significant 11.17% decline in one day, with a market capitalization of $2.46 million. Investor sentiment on Pluang shows a strong sell bias, with 100% of order activity directed towards selling and a typical holding period of 31 days.